According to a new research, asthmatics with mild asthma can effectively manage their ailment with a twice-daily use of inhaled steroids or switching to a daily pill.

Stephen P. Peters, M.D., Ph.D., lead author and a professor of pediatrics, internal medicine-pulmonary and associate director of the Center for Human Genomics, remarked that this is good news for asthma patients with a mild and persistent form of the disease as it offers them more choices when it comes to disease management.

The results were reported in the May 17 issue of the New England Journal of Medicine.

From News-Medical.Net:

Asthma is considered mild, but persistent, when symptoms occur more than two times a week or cause the patient to awaken during the night more than twice a month. The standard treatment for mild-persistent asthma is twice-daily use of an inhaled steroid to prevent symptoms. Patients may also take additional drugs such as the inhaler albuterol, known as “rescue” therapy, to treat symptoms. A majority of people with asthma have mild disease, according to Peters.

The study involved patients whose asthma was treated with twice-daily inhaled fluticasone propionate (Flovent Discus), a commonly prescribed synthetic steroid. This drug is designed to suppress inflammation within the airways that can cause narrowing.

Peters said that the study suggests that patients administered with twice-daily fluticasone and managing their ailment effectively may be switched to once-daily flucitasone/salmeterol without increased rates of treatment failure. He also said that montelukast, which fairs poorly when compared to inhaled medications, may still be considered as an option as a majority of patients also did well on this treatment.

Tags: albuterol, Asthma, fluticasone, Inhaled steroids, steroids

Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids